alex3619
Senior Member
- Messages
- 13,810
- Location
- Logan, Queensland, Australia
Hi lululowry
Agreed, especially if the link extends to many cases of autism, and if by studying xmrv+ patients with autism somebody is finally able to prove the hypothesised autism-vaccine link. However, they will then do a risk asssessment. They will have to decide if the profit to be made, ongoing, is better than the cost they incur. It might be.
Two complicating factors are here. The first is that xmrv might determine risk if being vaccinated, so we will finally have a diagnostic test to determine those who respond badly to vaccines - and these people will need very expensive drugs. So they lose the vaccine profit, gain money on a universal diagnostic test (look for Big Pharma to buy the rights), and then make money by selling much more profitable treatments than vaccines could ever be.
The second, is that they can easily claim no prior knowledge of risk, and so may not be liable for past problems. On the other hand, if they cover up research then the future class action lawsuit could seriuosly damage their bottom line, particularly a world wide class action of many millions of people each claiming hundreds of thousands to millions in damages, not to mention potential criminal charges. The damage to Big Pharma's reputation if they are eventually caught will also have to factor in.
I think it more likely that the risk is such that most companies will not stay the party line and will indeed support xmrv research and treatment. There is probably much more money to be made this way, but we would need forensic accountants with access to their books, etc, to be sure. There is also much less risk.
By this analysis, Big Pharma A might be limited in scope, probably only those companies who don't have a drug for treating xmrv, and Big Pharma B will be all the rest.
Bye
Alex
Agreed, especially if the link extends to many cases of autism, and if by studying xmrv+ patients with autism somebody is finally able to prove the hypothesised autism-vaccine link. However, they will then do a risk asssessment. They will have to decide if the profit to be made, ongoing, is better than the cost they incur. It might be.
Two complicating factors are here. The first is that xmrv might determine risk if being vaccinated, so we will finally have a diagnostic test to determine those who respond badly to vaccines - and these people will need very expensive drugs. So they lose the vaccine profit, gain money on a universal diagnostic test (look for Big Pharma to buy the rights), and then make money by selling much more profitable treatments than vaccines could ever be.
The second, is that they can easily claim no prior knowledge of risk, and so may not be liable for past problems. On the other hand, if they cover up research then the future class action lawsuit could seriuosly damage their bottom line, particularly a world wide class action of many millions of people each claiming hundreds of thousands to millions in damages, not to mention potential criminal charges. The damage to Big Pharma's reputation if they are eventually caught will also have to factor in.
I think it more likely that the risk is such that most companies will not stay the party line and will indeed support xmrv research and treatment. There is probably much more money to be made this way, but we would need forensic accountants with access to their books, etc, to be sure. There is also much less risk.
By this analysis, Big Pharma A might be limited in scope, probably only those companies who don't have a drug for treating xmrv, and Big Pharma B will be all the rest.
Bye
Alex
I totally agree with this point Alex. AND Big Pharma is not one entity.
There is Big Pharma A that has profitted and continues to profit from government-mandated vaccines. If any vaccine turns out to play a role in having activated (sorry if this is not the right word) or exacerbated xmrv, watch out. That's Big Pharma + Big Brother combined to fight like heck against monster liability and loss of billions vaccine income if major problems are revealed.
On the other hand, there is Big Pharma B which stand to make billions on xmrv drugs.
Battle of the titans...